CAD 0.07
(0.0%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 1.24 Million CAD | 88.66% |
2022 | 661.23 Thousand CAD | 177.34% |
2021 | -855.02 Thousand CAD | -1751.91% |
2020 | -46.17 Thousand CAD | 90.66% |
2019 | -494.51 Thousand CAD | -286.67% |
2018 | -127.89 Thousand CAD | -1638.82% |
2017 | -7355.00 CAD | 0.0% |
2016 | - CAD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q3 | 884.34 Thousand CAD | 242.24% |
2024 Q2 | -621.71 Thousand CAD | -198.36% |
2024 Q1 | 632.09 Thousand CAD | 12.46% |
2023 Q2 | 448.01 Thousand CAD | 1676.78% |
2023 Q1 | 25.21 Thousand CAD | 225.31% |
2023 FY | 1.24 Million CAD | 88.66% |
2023 Q4 | 562.03 Thousand CAD | -18.33% |
2023 Q3 | 688.16 Thousand CAD | 53.6% |
2022 Q4 | 7751.00 CAD | 106.96% |
2022 Q3 | -111.37 Thousand CAD | -126.43% |
2022 Q2 | 421.44 Thousand CAD | 22.72% |
2022 Q1 | 343.41 Thousand CAD | 190.87% |
2022 FY | 661.23 Thousand CAD | 177.34% |
2021 FY | -855.02 Thousand CAD | -1751.91% |
2021 Q2 | -445.17 Thousand CAD | -847.08% |
2021 Q3 | -57.58 Thousand CAD | 87.07% |
2021 Q4 | -377.9 Thousand CAD | -556.28% |
2021 Q1 | 59.58 Thousand CAD | 111.88% |
2020 Q4 | -501.38 Thousand CAD | 0.0% |
2020 Q1 | 350 Thousand CAD | 0.0% |
2020 Q2 | 105.21 Thousand CAD | -69.94% |
2020 FY | -46.17 Thousand CAD | 90.66% |
2020 Q3 | - CAD | -100.0% |
2019 Q3 | - CAD | 100.0% |
2019 FY | -494.51 Thousand CAD | -286.67% |
2019 Q4 | - CAD | 0.0% |
2019 Q2 | -110.36 Thousand CAD | -3091.61% |
2019 Q1 | -3458.00 CAD | 55.44% |
2018 Q1 | -39.1 Thousand CAD | 73.44% |
2018 Q2 | -210.97 Thousand CAD | -439.52% |
2018 FY | -127.89 Thousand CAD | -1638.82% |
2018 Q3 | -5106.00 CAD | 97.58% |
2018 Q4 | -7760.00 CAD | -51.98% |
2017 FY | -7355.00 CAD | 0.0% |
2017 Q3 | - CAD | 0.0% |
2017 Q4 | -147.24 Thousand CAD | 0.0% |
2016 FY | - CAD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Aion Therapeutic Inc. | -285.33 Thousand CAD | 537.192% |
Ayurcann Holdings Corp. | 8.46 Million CAD | 85.264% |
Blueberries Medical Corp. | 84.22 Thousand CAD | -1381.107% |
The BC Bud Corporation | 59.5 Thousand CAD | -1996.469% |
BioNxt Solutions Inc. | 372.24 Thousand CAD | -235.117% |
CordovaCann Corp. | 3.26 Million CAD | 61.845% |
Christina Lake Cannabis Corp. | 3.46 Million CAD | 64.01% |
Captor Capital Corp. | 16.93 Million CAD | 92.635% |
City View Green Holdings Inc. | -290.73 Thousand CAD | 529.067% |
1CM Inc. | 7.6 Million CAD | 83.605% |
Global Hemp Group Inc. | - CAD | -Infinity% |
Greenway Greenhouse Cannabis Corporation | -335.37 Thousand CAD | 471.958% |
IM Cannabis Corp. | 9.84 Million CAD | 87.33% |
Lobe Sciences Ltd. | 772.82 Thousand CAD | -61.416% |
Maple Leaf Green World Inc. | -17.85 Thousand CAD | 7087.017% |
Mountain Valley MD Holdings Inc. | -346 Thousand CAD | 460.538% |
Ovation Science Inc. | -251.43 Thousand CAD | 596.145% |
Pharmadrug Inc. | -26.21 Thousand CAD | 4858.399% |
Captiva Verde Wellness Corp. | 163.43 Thousand CAD | -663.291% |
RAMM Pharma Corp. | -902.83 Thousand CAD | 238.171% |
RIV Capital Inc. | -958.27 Thousand CAD | 230.177% |
Revive Therapeutics Ltd. | -328.00 CAD | 380423.78% |
Red White & Bloom Brands Inc. | 29.48 Million CAD | 95.769% |
SLANG Worldwide Inc. | 18.61 Million CAD | 93.3% |
1933 Industries Inc. | -602.75 Thousand CAD | 306.959% |
Red Light Holland Corp. | 2.02 Million CAD | 38.259% |
Top Strike Resources Corp. | 2.84 Million CAD | 56.183% |
Xebra Brands Ltd. | -367.96 Thousand CAD | 439.017% |
Adastra Holdings Ltd. | 7.03 Million CAD | 82.256% |